Safety of HMA-CD20 in Patients With HFrEF
NCT03332888
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Heart Failure With Reduced Ejection Fraction
Interventions
DRUG:
Rituximab
Sponsor
Instituto de Cardiología y Medicina Vascular Hospital Zambrano-Hellion Tec Salud